Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 5, 2011, Pages 479-484

  Goldstein, Benjamin I ^a,b   Collinger, Katelyn A ^a   Lotrich, Francis ^b   Marsland, Anna L ^c   Gill, Mary Kay ^b   Axelson, David A ^b   Birmaher, Boris ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; INTERLEUKIN 6; LITHIUM; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; VALPROATE SEMISODIUM;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; HYPOMANIA; MALE; MANIA; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; INTERLEUKIN-6; MALE;

EID: 80155139377     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0009     Document Type: Article

References (64)

1. Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F: Neuronal damage in brain inflammation. Arch Neurol 64:185-189, 2007.
2. Allan SM, Rothwell NJ: Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744, 2001.
3. Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Bridge J, Keller M: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 63:1139-1148, 2006.
4. Axelson D, Birmaher BJ, Brent D, Wassick S, Hoover C, Bridge J, Ryan N: A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol 13:463-470, 2003.
5. Banks WA, Farr SA, Morley JE: Entry of blood-borne cytokines into the central nervous system: Effects on cognitive processes. Neuroimmunomodulation 10:319-327, 2002.
6. Banks WA, Kastin AJ, Broadwell RD: Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2:241-248, 1995.
7. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, Esposito- Smythers C, Goldstein T, Ryan N, Keller M: Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 166:795-804, 2009.
8. Bosetti F, Rintala J, Seemann R, Rosenberger TA, Contreras MA, Rapoport SI, Chang MC: Chronic lithium downregulates cyclooxygenase- 2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry 7:845-850, 2002.
9. Bosetti F, Weerasinghe GR, Rosenberger TA, Rapoport SI: Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and 2 in rat brain. J Neurochem 85:690-696, 2003.
10. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F: Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116:214-217, 2009.
11. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M: The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry 42:696-702, 1985.
12. Correll CU: Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 46:687-700, 2007.
13. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R: Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:952-955, 2007.
14. Elzinga B, Molendijk M, Oude Voshaar R, Bus B, Prickaerts J, Spinhoven P, Penninx B: The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology 214:319-328, 2010.
15. Evans-Lacko SE, Zeber JE, Gonzalez JM, Olvera RL: Medical comorbidity among youth diagnosed with bipolar disorder in the United States. J Clin Psychiatry 70:1461-1466, 2009.
16. Frey BN, Andreazza AC, Cereser KMM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F: Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286, 2006.
17. Frey BN, Stanley JA, Nery FG, Monkul ES, Nicoletti MA, Chen H-H, Hatch JP, Caetano SC, Ortiz O, Kapczinski F, Soares JC: Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study. Bipolar Disord 9 Suppl 1:119-127, 2007.
18. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH, Jr.: Linkage Disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161:1698-1700, 2004.
19. Goldstein BI, Birmaher B, Axelson DA, Goldstein TR, Esposito- Smythers C, Strober MA, Hunt J, Leonard H, Gill MK, Iyengar S, Grimm C, Yang M, Ryan ND, Keller MB: Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry 69:1953-1959, 2008.
20. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ: Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 11:657-662, 2009a.
21. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature. J Clin Psychiatry 70:1078-1090, 2009b.
22. Gorgulu Y, Caliyurt O: Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull 80:158-162, 2009.
23. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr., Taylor AJ, Weintraub WS, Wenger NK: 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, merican Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. JACC 56:2182-2199, 2010.
24. Hamer M, Steptoe A: Association between physical fitness, parasympathetic control, and proinflammatory responses to mental stress. Psychosom Med 69:660-666, 2007.
25. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66:407-414, 2009.
26. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W: Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763-767, 2001.
27. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S: Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166:1756-1762, 2006.
28. Jerrell JM, McIntyre RS, Tripathi A: A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry 71:1518-1525, 2010.
29. Joe K-H, Kim Y-K, Kim T-S, Roh S-W, Choi S-W, Kim Y-B, Lee HJ, Kim D-J: Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol Clin Exp Res 31:1833-1838, 2007.
30. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PVS, Kauer-Sant'Anna M, Klamt F, de Bittencourt Pasquali MA, Quevedo J, Gama CS, Post R: A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15:784-786, 2010.
31. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E, Berk M: The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1366-1371, 2009.
32. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'Anna M, Grassi-Oliveira R, Post RM: Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675-692, 2008.
33. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN: Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12:447-458, 2009.
34. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
35. Kim Y-K, Jung H-G, Myint A-M, Kim H, Park S-H: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104:91-95, 2007.
36. Knijff EM, Breunis MN, van Geest MC, Kupka RW, Ruwhof C, de Wit HJ, Nolen WA, Drexhage HA: A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord 8:740-750, 2006.
37. Kraepelin E: Manic-Depressive Insanity and Paranoia. Edinburgh: E.S. Livingstone; 1921.
38. Lang UE, Hellweg R, Sander T, Gallinat J: The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 14:120-122, 2009.
39. Lin P-Y: State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: A meta-analytic study. Neurosci Lett 466:139-143, 2009.
40. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK: Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763-769, 2000.
41. Matsuo K, Walss-Bass C, Nery FG, Nicoletti MA, Hatch JP, Frey BN, Monkul ES, Zunta-Soares GB, Bowden CL, Escamilla MA, Soares JC: Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 34:1904-1913, 2009.
42. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 338:171-179, 1998.
43. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741, 2009.
44. O'Brien SM, Scully P, Scott LV, Dinan TG: Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J Affect Disord 90:263-267, 2006.
45. Ortiz-Dominguez A, Hernandez ME, Berlanga C, Gutierrez-Mora D, Moreno J, Heinze G, Pavon L: Immune variations in bipolar disorder: Phasic differences. Bipolar Disord 9:596-602, 2007.
46. Osby U, Brandt L, Correia N, Ekbom A, Sparen P: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58:844-850, 2001.
47. Pacifici R, Zuccaro P, Pichini S, Roset PN, Poudevida S, Farre M, Segura J, De la Torre R: Modulation of the immune system in cannabis users. JAMA 289:1929-1931, 2003.
48. Padmos RC, Hillegers MHJ, Knijff EM, Vonk R, Bouvy A, Staal FJT, de Ridder D, Kupka RW, Nolen WA, Drexhage HA: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65:395-407, 2008.
49. Pandey GN, Rizavi HS, Dwivedi Y, Pavuluri MN: Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: Effects of treatment and clinical response. J Am Acad Child Adolesc Psychiatry 47:1077-1085, 2008.
50. Post RM: Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. J Psychiatr Res 41:979-990, 2007.
51. Rao JS, Harry GJ, Rapoport SI, Kim HW: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15:384-392, 2010.
52. Rapaport MH, Manji HK: The effects of lithium on ex vivo cytokine production. Biol Psychiatry 50:217-224, 2001.
53. Rapoport SI, Bosetti F: Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psychiatry 59:592-596, 2002.
54. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H: Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 94:1062-1069, 2009.
55. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Jr., Kastelein JJP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to prevent vascular events in men and women with elevated creactive protein. N Engl J Med 359:2195-2207, 2008.
56. Sen S, Duman R, Sanacora G: Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry 64:527-532, 2008.
57. Tang SW, Chu E, Hui T, Helmeste D, Law C: Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci Lett 431:62-65, 2008.
58. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J: 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet 374:620-627, 2009.
59. Tsuang MT, Woolson RF, Fleming JA: Causes of death in schizophrenia and manic-depression. Br J Psychiatry 136:239-242, 1980.
60. Weeke A, Juel K, Vaeth M: Cardiovascular death and manicdepressive psychosis. J Affect Disord 13:287-292, 1987.
61. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for family psychiatric history: The family history screen. Arch Gen Psychiatry 57:675-682, 2000.
62. Wersching H, Duning T, Lohmann H, Mohammadi S, Stehling C, Fobker M, Conty M, Minnerup J, Ringelstein EB, Berger K, Deppe M, Knecht S: Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 74:1022- 1029, 2010.
63. Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM: Effects of acute insulin-induced hypoglycemia on indices of inflammation: Putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33:1591-1597, 2010.
64. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM: The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14:51-59, 2009.